Eone Diagnomics Genome Center Co., Ltd.
KOSDAQ
₩0.00
+0.00%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of -2.95.
- Net profit margin is strong at 358.1%.
!Watch-points
- Return on equity is on the lower side at -125.4%.
- Return on capital employed is on the lower side at 9.9%.
- Current ratio of 0.32 is below 1, so current liabilities exceed current assets.
- Sales growth has been slow over five years (about -28% a year).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
-7.12
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Computed without the market-value term.
Piotroski F-ScoreWeak
2 / 5
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 5 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₩0
Current Price₩ 0.00
High / Low₩ 2,489.50 / 415.00
Stock P/E12.20
Book Value₩ -162.74
ROCE9.92%
ROE-125.38%
Debt to Equity-2.95
Current Ratio0.32
EPS₩ 204.00
PAT Margin358.13%
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity